Search - tctmd.com

Displaying 101 - 120 of 401

Sort: Relevancy | Date

News Daily News

Positive Phase III Results Bring Excitement for Novel PET Imaging Tracer

Todd Neale

October 10, 2023

News Daily News

Angiogram-Derived Functional Tests Pre-TAVI: Simpler, Yes, but Warranted?

Michael O'Riordan

September 21, 2023

Presentation SCCT 2023

Epicardial Stenosis vs. Microvascular Disease: What’s Next with a ‘negative’ CCTA?

Presenter: Viviany R. Taqueti

July 28, 2023

News Daily News

More Angina Relief With Complete Revascularization in Stable CAD: ISCHEMIA

Michael O'Riordan

July 18, 2023

Presentation Complex Coronary Cases 2023

Coronary Microvascular Assessment and its Implications 2023

Presenter: Joseph M. Sweeny

June 14, 2023

News Conference News EuroPCR 2023

QFR More Consistent Than FFR in Nonculprit Lesions After STEMI

Caitlin E. Cox

May 24, 2023

News Daily News

First-Ever Cardiac Surgery Trial in Women Poised to Launch: ROMA-Women

Shelley Wood

April 07, 2023

News Daily News

Physiologic Testing May ID Patients Who’ll Still Have Angina After PCI

Michael O'Riordan

March 31, 2023

News Conference News ACC 2023

Diabetic Patients in Middle East, Africa Overburdened by ASCVD

Michael O'Riordan

March 14, 2023

News Daily News

Worse CABG Outcomes in Women Haven’t Budged in Over a Decade: STS

L.A. McKeown

March 03, 2023

News Daily News

FFR Pullback Measure Linked to Likelihood of Angina Relief After PCI

Todd Neale

December 02, 2022

News Conference News AHA 2022

Chinese Medicine Tongxinluo Yields ‘Surprising’ Benefits Post-STEMI: CTS-AMI

Shelley Wood

November 10, 2022

News Daily News

INOCA Exerts Heavy Toll on Daily Life: Survey

Caitlin E. Cox

September 28, 2022

Presentation TCT 2022

Coronary Sinus Reduction for the Treatment of Symptomatic Microvascular Coronary Disease: Early Clinical Results

Presenter: Shmuel Banai

September 19, 2022

Presentation TCT 2022

TCT 305: The effect of diltiazem versus placebo on microvascular dysfunction assessed by serial continuous thermodilution measurements: results of the EDIT-CMD trial.

Presenter: Tijn Jansen

September 19, 2022

Presentation TCT 2022

TCT 304: Non-Invasive Assessment of Microvascular Dysfunction After Optimal Coronary Artery Stent Deployment; Insight From Acetyl Salicylic Elimination Trial (ASET) Japan

Presenter: Shinichiro Masuda

September 19, 2022

Presentation TCT 2022

TCT 303: Continuous versus bolus thermodilution derived CFR and MRR and their association with symptoms of CMD: a head-to-head comparison

Presenter: Tijn Jansen

September 19, 2022

Presentation TCT 2022

TCT 302: MRR by Continuous Thermodilution is not Influenced by the Ray Flow Catheter Effect on Coronary Resistance

Presenter: Alejandro Gutierrez-Barrios

September 19, 2022

Presentation TCT 2022

TCT 301: The role of the collateral circulation in stable coronary artery disease: a placebo-controlled study in patients with stable angina.

Presenter: Christopher Rajkumar

September 19, 2022

Presentation TCT 2022

TCT 300: The impact of coronary microvascular dysfunction on fractional flow reserve and resting full-cycle ratio discordance in the assessment of borderline coronary lesions

Presenter: Piotr Szolc

September 18, 2022

Advertisement

Positive Phase III Results Bring Excitement for Novel PET Imaging Tracer

Angiogram-Derived Functional Tests Pre-TAVI: Simpler, Yes, but Warranted?

Epicardial Stenosis vs. Microvascular Disease: What’s Next with a ‘negative’ CCTA?

More Angina Relief With Complete Revascularization in Stable CAD: ISCHEMIA

Coronary Microvascular Assessment and its Implications 2023

QFR More Consistent Than FFR in Nonculprit Lesions After STEMI

First-Ever Cardiac Surgery Trial in Women Poised to Launch: ROMA-Women

Physiologic Testing May ID Patients Who’ll Still Have Angina After PCI

Diabetic Patients in Middle East, Africa Overburdened by ASCVD

Worse CABG Outcomes in Women Haven’t Budged in Over a Decade: STS

FFR Pullback Measure Linked to Likelihood of Angina Relief After PCI

Chinese Medicine Tongxinluo Yields ‘Surprising’ Benefits Post-STEMI: CTS-AMI

INOCA Exerts Heavy Toll on Daily Life: Survey

Coronary Sinus Reduction for the Treatment of Symptomatic Microvascular Coronary Disease: Early Clinical Results

TCT 305: The effect of diltiazem versus placebo on microvascular dysfunction assessed by serial continuous thermodilution measurements: results of the EDIT-CMD trial.

TCT 304: Non-Invasive Assessment of Microvascular Dysfunction After Optimal Coronary Artery Stent Deployment; Insight From Acetyl Salicylic Elimination Trial (ASET) Japan

TCT 303: Continuous versus bolus thermodilution derived CFR and MRR and their association with symptoms of CMD: a head-to-head comparison

TCT 302: MRR by Continuous Thermodilution is not Influenced by the Ray Flow Catheter Effect on Coronary Resistance

TCT 301: The role of the collateral circulation in stable coronary artery disease: a placebo-controlled study in patients with stable angina.

TCT 300: The impact of coronary microvascular dysfunction on fractional flow reserve and resting full-cycle ratio discordance in the assessment of borderline coronary lesions

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content